Updates for c.571T>G:
2020-03-26 class changed from unclassified to disease-causing and subclass to CF-causing
2021-01-18 subclass updated from CF-causing to not defined




Variant NM_000492.4:c.571T>G


Variant details:
Name NM_000492.4:c.571T>G
Protein name NP_000483.3:p.(Phe191Val)
Genomic name (hg19)     chr7:g.117174411T>G    UCSC    
Genomic name (hg38) chr7:g.117534357T>G    UCSC
#Exon/intron exon 5
Legacy Name F191V
Class disease-causing
WT sequence TCTCCTTTCCAACAACCTGAACAAA T TTGATGAAGTATGTACCTATTGATT
Mutant sequence TCTCCTTTCCAACAACCTGAACAAA G TTGATGAAGTATGTACCTATTGATT

Other databases:

Not found		 dbSNP
rs141482808



Pathogenicity predictors:



Response to modulators:


Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVAnononono
TEZ-IVA yesnoyesno
ELX-TEZ-IVA yesnoyesno
VNZ-TEZ-DIVA yesnoyesno

clinical and functional data presented above are provided by Vertex


No patient found in CFTR-NGS catalogue


3 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 3
CFTR-RD3
  • CBAVD  1
  • Other  1
  • Pancreatitis  1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Other 5367heterozygoteCF-causing - Trans
CBAVD 2040heterozygotevarying clinical consequence- Undef
Pancreatitis 5611heterozygoteCFTR-RD-causing- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups (click here for more details about the classification of variants):
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare